

Andrew Dalton
EMEA Vice President, Johnson & Johnson MedTech, OrthopaedicsAndrew brings 30 years of healthcare industry experience, currently leading the Joint Reconstruction Business for Johnson & Johnson in the EMEA region. Over his 22-year tenure at J&J, he has held leadership roles across Orthopaedics in both the UK and EMEA, including five years managing the UK business. With a background in Clinical Diagnostics and Pharma, Andrew is known for driving commercial success and is passionate about developing future leaders.
Posted on 12.10.2024
From burden to breakthrough: Orthopaedic innovations for osteoarthritis care


By Andrew Dalton, EMEA Vice President, Johnson & Johnson MedTech, Orthopaedics